Predictors of total mortality and sudden death in mild to moderate heart failure. Captopril-Digoxin Study Group.

PubWeight™: 1.61‹?› | Rank: Top 4%

🔗 View Article (PMID 2768707)

Published in J Am Coll Cardiol on September 01, 1989

Authors

A Gradman1, P Deedwania, R Cody, B Massie, M Packer, B Pitt, S Goldstein

Author Affiliations

1: Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06510.

Articles citing this

Impact of converting enzyme inhibition on progression of chronic heart failure: results of the Munich Mild Heart Failure Trial. Br Heart J (1992) 2.99

Left ventricular atrioventricular plane displacement: an echocardiographic technique for rapid assessment of prognosis in heart failure. Heart (1997) 2.04

Changing epidemiological features of cardiac failure. Br Heart J (1994) 1.92

Importance of treadmill exercise time as an initial prognostic screening tool in patients with systolic left ventricular dysfunction. Circulation (2009) 1.63

Left ventricular global function index by magnetic resonance imaging--a novel marker for assessment of cardiac performance for the prediction of cardiovascular events: the multi-ethnic study of atherosclerosis. Hypertension (2013) 1.61

The need for palliative care in the management of heart failure. Heart (2002) 1.44

Triage after hospitalization with advanced heart failure: the ESCAPE (Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness) risk model and discharge score. J Am Coll Cardiol (2010) 1.44

Prognostic value of 6-minute walk test in stable outpatients with heart failure. Tex Heart Inst J (2007) 1.23

Safety and efficacy of sertraline for depression in patients with CHF (SADHART-CHF): a randomized, double-blind, placebo-controlled trial of sertraline for major depression with congestive heart failure. Am Heart J (2008) 1.18

Left ventricular systolic dysfunction induced by ventricular ectopy: a novel model for premature ventricular contraction-induced cardiomyopathy. Circ Arrhythm Electrophysiol (2011) 1.17

The adult Göttingen minipig as a model for chronic heart failure after myocardial infarction: focus on cardiovascular imaging and regenerative therapies. Comp Med (2008) 1.16

Predictors of fatal and non-fatal outcomes in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): incremental value of apolipoprotein A-1, high-sensitivity C-reactive peptide and N-terminal pro B-type natriuretic peptide. Eur J Heart Fail (2009) 1.09

What is treatment success in cardiac resynchronization therapy? Europace (2009) 1.02

Prognostic value of heart rate variability and ventricular arrhythmias during 13-year follow-up in patients with mild to moderate heart failure. Clin Res Cardiol (2009) 0.97

Assessing left ventricular systolic dysfunction after myocardial infarction: are ejection fraction and dP/dt(max) complementary or redundant? Am J Physiol Heart Circ Physiol (2012) 0.93

Prediction of sudden death in patients with mild-to-moderate chronic heart failure by using cardiac iodine-123 metaiodobenzylguanidine imaging. Heart (2007) 0.93

Impaired cardiac adrenergic innervation assessed by MIBG imaging as a predictor of treatment response in childhood dilated cardiomyopathy. Heart (2001) 0.91

A potential role for integrin signaling in mechanoelectrical feedback. Prog Biophys Mol Biol (2012) 0.84

Clinical validation of the gated blood pool SPECT QBS processing software in congestive heart failure patients: correlation with MUGA, first-pass RNV and 2D-echocardiography. Int J Cardiovasc Imaging (2005) 0.83

Systemic inflammation in nonischemic dilated cardiomyopathy. Heart Vessels (2008) 0.82

Clinical value of B-type natriuretic peptide for the assessment of left ventricular filling pressures in patients with systolic heart failure and inconclusive tissue Doppler indexes. Heart Vessels (2008) 0.82

Exercise capacity in chronic heart failure is related to the aetiology of heart disease. Heart (1997) 0.82

Quantifying late gadolinium enhancement on CMR provides additional prognostic information in early risk-stratification of nonischemic cardiomyopathy: a cohort study. BMC Cardiovasc Disord (2014) 0.81

Sudden cardiac death risk stratification. Circ Res (2015) 0.81

Ventricular arrhythmias in congestive heart failure: clinical significance and management. Tex Heart Inst J (1999) 0.80

Prognostic value of left atrium remodeling after primary percutaneous coronary intervention in patients with ST elevation acute myocardial infarction. J Korean Med Sci (2012) 0.79

Overview of implantable cardioverter defibrillator and cardiac resynchronisation therapy in heart failure management. Singapore Med J (2016) 0.78

A patient with severely reduced LV function and electrical storm saved by wearable cardioverter-defibrillator: a case report. Herzschrittmacherther Elektrophysiol (2013) 0.76

Devices for the management of ventricular arrhythmias in cardiac failure. Heart Fail Rev (2002) 0.76

Left ventricular end-systolic stress/diameter relation as a contractility index and as a predictor of survival. Independence of preload after normalization for end-diastolic diameter. Heart Vessels (2005) 0.75

Changes in Myocardial Composition and Conduction Properties in Rat Heart Failure Model Induced by Chronic Volume Overload. Front Physiol (2016) 0.75

Device Management in Heart Failure. Curr Cardiol Rep (2017) 0.75

Global improvement in left ventricular performance observed with cardiac contractility modulation is the result of changes in regional contractility. Heart Fail Rev (2001) 0.75

Articles by these authors

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med (1999) 29.32

Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci U S A (1992) 10.19

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. The SOLVD Investigattors. N Engl J Med (1992) 8.38

Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions. Lancet (1992) 7.22

Sex differences in the management of coronary artery disease. Survival and Ventricular Enlargement Investigators. N Engl J Med (1991) 6.16

Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med (1990) 5.65

Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group. JAMA (2000) 5.49

Increased bone formation in osteocalcin-deficient mice. Nature (1996) 4.91

ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol (2001) 4.89

Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival With Oral d-Sotalol. Lancet (1996) 4.61

Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara. J Virol (1996) 4.29

The on-call experience of interns in internal medicine. Medical Education Task Force of Henry Ford Hospital. Arch Intern Med (1990) 4.26

ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration With the International Society for Heart and Lung Transplantation; Endorsed by the Heart Failure Society of America. Circulation (2001) 4.24

Management of heart failure. I. Pharmacologic treatment. JAMA (1994) 4.07

Laser capture microdissection: molecular analysis of tissue. Science (1997) 3.93

The extent of early viral replication is a critical determinant of the natural history of simian immunodeficiency virus infection. J Virol (1997) 3.77

Dipyridamole thallium-201 scintigraphy as a preoperative screening test. A reexamination of its predictive potential. Study of Perioperative Ischemia Research Group. Circulation (1991) 3.63

Race and the response to adrenergic blockade with carvedilol in patients with chronic heart failure. N Engl J Med (2001) 3.44

Obliquity-paced Pliocene West Antarctic ice sheet oscillations. Nature (2009) 3.42

Role of the human heat shock protein hsp70 in protection against stress-induced apoptosis. Mol Cell Biol (1997) 3.39

Transplantation of cultured human neuronal cells for patients with stroke. Neurology (2000) 3.38

"Atypical" depression following childbirth. Br J Psychiatry (1968) 3.32

Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study. Circulation (1996) 3.28

Sex bias and underutilization of lipid-lowering therapy in patients with coronary artery disease at academic medical centers in the United States and Canada. Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial (PREVENT) Investigators. Arch Intern Med (2000) 3.25

Vpx is required for dissemination and pathogenesis of SIV(SM) PBj: evidence of macrophage-dependent viral amplification. Nat Med (1998) 3.19

Age-related changes in oxidized proteins. J Biol Chem (1987) 3.18

Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study Group. Circulation (1996) 3.14

A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction. N Engl J Med (1987) 3.04

Induction of AIDS by simian immunodeficiency virus from an African green monkey: species-specific variation in pathogenicity correlates with the extent of in vivo replication. J Virol (1995) 2.96

Psychological factors related to prehospital delay during acute myocardial infarction. Circulation (1991) 2.88

Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration. Nat Med (1999) 2.84

Targeted disruption of the biglycan gene leads to an osteoporosis-like phenotype in mice. Nat Genet (1998) 2.84

Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation. J Clin Oncol (1993) 2.79

Thallium-201 for myocardial imaging. Relation of thallium-201 to regional myocardial perfusion. Circulation (1975) 2.77

Guidelines for the early management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee to Develop Guidelines for the Early Management of Patients with Acute Myocardial Infarction) J Am Coll Cardiol (1990) 2.70

Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure. Circulation (1986) 2.69

The chaperone function of hsp70 is required for protection against stress-induced apoptosis. Mol Cell Biol (2000) 2.69

Medical care costs and quality of life after randomization to coronary angioplasty or coronary bypass surgery. Bypass Angioplasty Revascularization Investigation (BARI) Investigators. N Engl J Med (1997) 2.65

Comparative efficacy of recombinant modified vaccinia virus Ankara expressing simian immunodeficiency virus (SIV) Gag-Pol and/or Env in macaques challenged with pathogenic SIV. J Virol (2000) 2.65

Ultrasequencing of the meiofaunal biosphere: practice, pitfalls and promises. Mol Ecol (2010) 2.64

Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection. Circulation (1994) 2.61

The heart in hypertension. N Engl J Med (1992) 2.53

Acute coronary findings at autopsy in heart failure patients with sudden death: results from the assessment of treatment with lisinopril and survival (ATLAS) trial. Circulation (2000) 2.49

Human CD4+ cells transfected with IL-16 cDNA are resistant to HIV-1 infection: inhibition of mRNA expression. Nat Med (1997) 2.47

A molecularly cloned, pathogenic, neutralization-resistant simian immunodeficiency virus, SIVsmE543-3. J Virol (1997) 2.46

The route of administration is a major determinant of the transduction efficiency of rat tissues by adenoviral recombinants. Gene Ther (1995) 2.39

Clinical effects of beta-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled, randomized trials. Circulation (1998) 2.35

A critical appraisal of milieu therapy in a geriatric day hospital. J Am Geriatr Soc (1971) 2.27

The REMATCH trial: rationale, design, and end points. Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure. Ann Thorac Surg (1999) 2.26

Thallium-201 myocardial perfusion imaging at rest and during exercise. Comparative sensitivity to electrocardiography in coronary artery disease. Circulation (1977) 2.22

BASDEC: a novel screening instrument for depression in elderly medical inpatients. BMJ (1992) 2.21

Early revascularization improves survival in cardiogenic shock complicating acute myocardial infarction. J Am Coll Cardiol (1992) 2.18

Intracoronary fibrinolytic therapy in acute myocardial infarction. Report of a prospective randomized trial. N Engl J Med (1983) 2.18

The genetic fate of molecularly cloned simian immunodeficiency virus in experimentally infected macaques. Virology (1991) 2.15

Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the randomized aldactone evaluation study (RALES). Rales Investigators. Circulation (2000) 2.15

The EPHESUS trial: eplerenone in patients with heart failure due to systolic dysfunction complicating acute myocardial infarction. Eplerenone Post-AMI Heart Failure Efficacy and Survival Study. Cardiovasc Drugs Ther (2001) 2.13

Reye's syndrome: a case control study of medication use and associated viruses in Australia. Cleve Clin J Med (1990) 2.11

A canine model of chronic heart failure produced by multiple sequential coronary microembolizations. Am J Physiol (1991) 2.08

A noninvasive scintiphotographic method for detecting regional ventricular dysfunction in man. N Engl J Med (1971) 2.05

N-terminal proatrial natriuretic factor. An independent predictor of long-term prognosis after myocardial infarction. Circulation (1994) 2.05

Effect of ischemia and antianginal drugs on the distribution of radioactive microspheres in the canine left ventricle. Circ Res (1971) 2.05

Mindwandering and cognitive structure. Trans N Y Acad Sci (1970) 2.03

Oral flecainide acetate for the treatment of ventricular arrhythmias. N Engl J Med (1981) 1.99

The TrkB-Shc site signals neuronal survival and local axon growth via MEK and P13-kinase. Neuron (2000) 1.95

Variability of DNA methylation patterns during serial passage of human diploid fibroblasts. Proc Natl Acad Sci U S A (1982) 1.95

Effects of propranolol in non-Q-wave acute myocardial infarction in the beta blocker heart attack trial. Am J Cardiol (1990) 1.94

Predictors of clinical course, coronary anatomy and left ventricular function after recovery from acute myocardial infarction. Circulation (1980) 1.88

Comparison of captopril and enalapril in patients with severe chronic heart failure. N Engl J Med (1986) 1.79

Diabetes mellitus and aging: diminished planting efficiency of cultured human fibroblasts. Proc Natl Acad Sci U S A (1969) 1.78

Delay in hospitalization during the acute coronary period. Am J Cardiol (1969) 1.77

A density gradient ultracentrifugal procedure for the isolation of the major lipoprotein classes from human serum. J Lipid Res (1981) 1.77

Sudden death in the year following myocardial infarction. Relation to ventricular premature contractions in the late hospitals phase and left ventricular ejection fraction. Am J Med (1977) 1.77

The DNA-binding activity of the human heat shock transcription factor is regulated in vivo by hsp70. Mol Cell Biol (1993) 1.76

Paradoxical use of a demand pacemaker in treatment of supraventricular tachycardia due to the Wolff-Parkinson-White syndrome. Observation on termination of reciprocal rhythm. Circulation (1968) 1.75

Left ventricular shape is the primary determinant of functional mitral regurgitation in heart failure. J Am Coll Cardiol (1992) 1.75

Emergence of early region 1-containing replication-competent adenovirus in stocks of replication-defective adenovirus recombinants (delta E1 + delta E3) during multiple passages in 293 cells. Hum Gene Ther (1994) 1.74

Prevention and reversal of nitrate tolerance in patients with congestive heart failure. N Engl J Med (1987) 1.71

Effects of captopril on ischemic events after myocardial infarction. Results of the Survival and Ventricular Enlargement trial. SAVE Investigators. Circulation (1994) 1.67

Multidisciplinary baseline assessment of homosexual men with and without human immunodeficiency virus infection. III. Neurologic and neuropsychological findings. Arch Gen Psychiatry (1991) 1.67

Familial deficiency of apolipoproteins A-I and C-III and precocious coronary-artery disease. N Engl J Med (1982) 1.67

Abnormal left ventricular filling: an early finding in mild to moderate systemic hypertension. Am J Cardiol (1984) 1.66

Sudden unexpected death in patients with congestive heart failure: a second frontier. Circulation (1985) 1.65

Infants of depressed mothers show "depressed" behavior even with nondepressed adults. Child Dev (1988) 1.65

Effect of long-term digoxin therapy on autonomic function in patients with chronic heart failure. J Am Coll Cardiol (1995) 1.63

Changes in p53 and cyclin D1 protein levels and cell proliferation in different stages of human esophageal and gastric-cardia carcinogenesis. Int J Cancer (1994) 1.63

Donor leukocyte infusions in acute lymphocytic leukemia. Bone Marrow Transplant (2000) 1.62

The effect of bystander CPR on survival of out-of-hospital cardiac arrest victims. Am Heart J (1985) 1.61

Do nitroxide antioxidants act as scavengers of O2-. or as SOD mimics? J Biol Chem (1996) 1.59

The normalcy of self-proclaimed "normal volunteers". Am J Psychiatry (1989) 1.59

Mood changes and "on-off" phenomena in Parkinson's disease. Mov Disord (1990) 1.59

A distinct African lentivirus from Sykes' monkeys. J Virol (1993) 1.58

Effects of cigarette smoking and propranolol in survivors of acute myocardial infarction. Am J Cardiol (1990) 1.58

Use of phentolamine in acute myocardial infarction associated with hypertension and left ventricular failure. Circulation (1973) 1.57

Abnormal brachial artery flow-mediated vasodilation in young adults with major depression. Am J Cardiol (2001) 1.57

Independent prognostic information provided by sphygmomanometrically determined pulse pressure and mean arterial pressure in patients with left ventricular dysfunction. J Am Coll Cardiol (1999) 1.56

Myocardial infarction and cardiac mortality in the Bypass Angioplasty Revascularization Investigation (BARI) randomized trial. Circulation (1997) 1.56